Article Cited by others


DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer

Liu Wennuan

Year : 2016| Volume: 18| Issue : 4 | Page no: 533-542

   This article has been cited by
1 Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer
Renée Laufer-Amorim,Carlos Fonseca-Alves,Rolando Villacis,Sandra Linde,Marcio Carvalho,Simon Larsen,Fabio Marchi,Silvia Rogatto
International Journal of Molecular Sciences. 2019; 20(7): 1555
[Pubmed]  [Google Scholar] [DOI]
2 Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer
Dana Hashim,Amparo G. Gonzalez-Feliciano,Thomas U. Ahearn,Andreas Pettersson,Lauren Barber,Claire H. Pernar,Ericka M. Ebot,Masis Isikbay,Stephen P. Finn,Edward L. Giovannucci,Rosina T. Lis,Massimo Loda,Giovanni Parmigiani,Tamara Lotan,Philip W. Kantoff,Lorelei A. Mucci,Rebecca E. Graff
International Journal of Cancer. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer
Ann Erlandsson,Jessica Carlsson,Sven-Olof Andersson,Chraig Vyas,Pernilla Wikström,Ove Andrén,Sabina Davidsson,Jennifer R. Rider
Scandinavian Journal of Urology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
4 The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss
Deon O’Bryant,Zhengxin Wang
Oncogene. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Improving the genetic signature of prostate cancer, the somatic mutations
Luis Javier Martinez-Gonzalez,Manrique Pascual Geler,Inmaculada Robles Fernandez,Jose Manuel Cozar,Jose Antonio Lorente,Maria Jesus Alvarez Cubero
Urologic Oncology: Seminars and Original Investigations. 2018;
[Pubmed]  [Google Scholar] [DOI]


Read this article